40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.92%
Positive growth while CRK shows revenue decline. John Neff would investigate competitive advantages.
4.48%
Cost increase while CRK reduces costs. John Neff would investigate competitive disadvantage.
1.42%
Positive growth while CRK shows decline. John Neff would investigate competitive advantages.
-1.46%
Margin decline while CRK shows 2.02% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.40%
Other expenses growth while CRK reduces costs. John Neff would investigate differences.
2.81%
Operating expenses growth while CRK reduces costs. John Neff would investigate differences.
3.86%
Total costs growth while CRK reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
-6.47%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-6.50%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
27.50%
EBITDA margin growth exceeding 1.5x CRK's 1.65%. David Dodd would verify competitive advantages.
-0.43%
Both companies show declining income. Martin Whitman would check industry conditions.
-3.26%
Operating margin decline while CRK shows 5.26% growth. Joel Greenblatt would examine position.
-434.26%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-50.42%
Both companies show declining income. Martin Whitman would check industry conditions.
-51.83%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-12.67%
Both companies reducing tax expense. Martin Whitman would check patterns.
-57.44%
Net income decline while CRK shows 7.99% growth. Joel Greenblatt would examine position.
-58.65%
Net margin decline while CRK shows 15.27% growth. Joel Greenblatt would examine position.
-58.54%
EPS decline while CRK shows 0.00% growth. Joel Greenblatt would examine position.
-58.75%
Diluted EPS decline while CRK shows 11.11% growth. Joel Greenblatt would examine position.
3.43%
Share count reduction below 50% of CRK's 0.21%. Michael Burry would check for concerns.
2.60%
Diluted share increase while CRK reduces shares. John Neff would investigate differences.